@article{ATM4799,
author = {Camilo Pena and Leonardo Mirandola and Jose A. Figueroa and Nattamol Hosiriluck and Natallia Suvorava and Kayley Trotter and Adair Reidy and Rahman Rakhshanda and Drew Payne and Marjorie Jenkins and Fabio Grizzi and Lauren Littlefield and Maurizio Chiriva-Internati and Everardo Cobos},
title = {Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness},
journal = {Annals of Translational Medicine},
volume = {2},
number = {9},
year = {2014},
keywords = {},
abstract = {Galectins are family of galactose-binding proteins known to play critical roles in inflammation and neoplastic progression. Galectins facilitate the growth and survival of neoplastic cells by regulating their cross-talk with the extracellular microenvironment and hampering anti-neoplastic immunity. Here, we review the role of galectins in the biology of hematological malignancies and their promise as potential therapeutic agents in these diseases.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/4799}
}